School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Department of Pediatric Endocrinology, School of Medicine, Kazerun Branch, Islamic Azad University, Kazerun, Iran.
BMC Pediatr. 2021 Jun 5;21(1):264. doi: 10.1186/s12887-021-02729-6.
There is no data on the number as well as the prevalence of congenital hypothyroidism (CH) in the Fars province. Hence, we designed this study to analyze the latest data and the possible predictive factors on transient and permanent CH in this province.
This cross sectional study is based on the Fars province screening data from 2013 to 2016. A total of 294,214 newborns were screened with 938 confirmed cases of CH, which were included in this study. After recall and completion of the missing data, follow-up data for 642 CH cases with thyroid stimulating hormone (TSH) concentrations and levothyroxine doses for ten outpatient visits and final transient vs. permanent CH diagnosis were included.
The incidence rate was 1:313.66, and out of the 642 CH cases, 66.04 % had permanent CH, while 33.96 % had transient CH. TSH level trend during the outpatient visits were not statistically different between the two groups (P = 0.312). A cutoff point of > 2.25 levothyroxine µg/kg (sensitivity: 76.11 %, specificity: 58.52 %) at the third year and a TSH concentration of > 43.35 mIU/L at the venous sampling (initial TSH) (sensitivity: 31.66 %, specificity: 90.32 %) were the predictive factors for permanent CH.
Fars province has one of the highest incidence rate of CH in Iran. Levothyroxine dose at the 3rd year and the 1st venous TSH sample are the predictive factors for permanent CH in the Iranian population; however, TSH concentrations during follow ups are unreliable predictors.
法尔斯省先天性甲状腺功能减退症(CH)的病例数量和流行率尚无数据。因此,我们设计了这项研究,以分析该省最新的关于暂时性和永久性 CH 的数据和可能的预测因素。
这项横断面研究基于 2013 年至 2016 年法尔斯省的筛查数据。共有 294214 名新生儿接受了筛查,其中有 938 例确诊为 CH,这些病例都被纳入了本研究。在召回和补充了缺失数据后,共纳入了 642 例 CH 病例的随访数据,这些患儿的促甲状腺激素(TSH)浓度和左旋甲状腺素剂量随访了 10 次就诊,最终诊断为暂时性或永久性 CH。
发病率为 1:313.66,642 例 CH 病例中,永久性 CH 占 66.04%,暂时性 CH 占 33.96%。两组患儿门诊 TSH 水平趋势无统计学差异(P=0.312)。第 3 年左旋甲状腺素剂量>2.25μg/kg(灵敏度:76.11%,特异性:58.52%)和静脉取样初始 TSH 浓度>43.35mIU/L(灵敏度:31.66%,特异性:90.32%)是永久性 CH 的预测因素。
法尔斯省是伊朗先天性甲状腺功能减退症发病率最高的省份之一。伊朗人群中,第 3 年左旋甲状腺素剂量和第 1 次静脉 TSH 样本是永久性 CH 的预测因素;然而,随访期间的 TSH 浓度是不可靠的预测因素。